DCC-3116 is an orally active ULK1/2 inhibitor. DCC-3116 can inhibit autophagy in lung cancer cells by inhibiting KRASG12C signaling, thereby inhibiting the proliferation of lung cancer cells and exerting anti-cancer effects[1].
Molecular Weight:
535.60
Purity:
99.25
CAS Number:
[2543673-19-2]
Formula:
C26H36F3N7O2
Target:
Autophagy,Ras,ULK
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
